Cases & Deals

  • Home
  • Practices
  • Swiss Diabetes Venture Fund participates in €7 million financing of BOYDSense

Share

Swiss Diabetes Venture Fund participates in €7 million financing of BOYDSense

March 2024

Client(s) Swiss Diabetes Venture Fund

Jones Day advised Swiss Diabetes Venture Fund, lead investor with Bioserenity, in the €7 million financing of BOYDSense, a French medical device company that is developing a non-invasive glucose monitoring device via exhaled breath.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.